Can I read mGPS as a Predictor for TBP in ICI on EtoBox?

mGPS as a Predictor for TBP in ICI by estudos.pv.2023 is a document available to read on EtoBox.

What is mGPS as a Predictor for TBP in ICI about?

The modified Glasgow Prognostic Score (mGPS) serves as a predictive biomarker to identify patients who may benefit from immunotherapy treatment beyond progression (TBP) in various cancers. A post-hoc analysis of three phase 3 trials demonstrated that patients with low-risk mGPS at the time of disease progression had significantly better post-progression overall survival compared to those with high-risk mGPS. These findings suggest that mGPS can guide clinical decisions regarding continued immunotherapy in p

Author

estudos.pv.2023

Language

EN